- 全部删除
- 您的购物车当前为空
LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2]
LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2]
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 μg | ¥ 2,320 | 35日内发货 | |
50 μg | ¥ 4,390 | 35日内发货 | |
100 μg | ¥ 8,290 | 35日内发货 |
产品描述 | LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2] |
别名 | LTF4 |
分子量 | 568.72 |
分子式 | C28H44N2O8S |
CAS No. | 83851-42-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | DMF: >50 mg/mL (per Ramki Iyer) Ethanol: >50 mg/mL (per Ramki Iyer) DMSO: >50 mg/mL (per Ramki Iyer) |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容